natgillin/translations-raw huggingface dataset:
The full EPAR for Docetaxel Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports. 
ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
The Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Docetaxel Teva has been shown to have comparable quality to Taxotere. 
Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da je bilo v skladu z zahtevami EU dokazano, da je zdravilo Docetaxel Teva primerljivo z zdravilom Taxotere.
• non-small cell lung cancer. 
• nedrobnoceličnem pljučnem raku.
Other information about Docetaxel Teva 
Druge informacije o zdravilu Docetaxel Teva
Docetaxel Teva is used with cisplatin and 5-fluorouracil. 
Zdravilo Docetaxel Teva se uporablja s cisplatinom in 5-fluoroacilom.
What benefit and risk of Docetaxel Teva? 
Kakšne so koristi in tveganja, povezani z zdravilom Docetaxel Teva?
Dexamethasone (an anti-inflammatory medicine) should also be given to the patient, starting on the day before the Docetaxel Teva infusion. 
Bolniku je treba dati tudi deksametazon (protivnetno zdravilo), in sicer dan pred infuzijo zdravila Docetaxel Teva.
• gastric adenocarcinoma (a type of stomach cancer) in patients who have not yet received any treatment for their cancer. 
• adenokarcinomu želodca (vrste želodčnega raka) pri bolnikih, ki se zaradi raka še niso zdravili.
Because Docetaxel Teva is a generic medicine, the company has provided data from the published literature on docetaxel. 
Ker je zdravilo Docetaxel Teva generično zdravilo, je družba predložila podatke iz objavljene literature o učinkovini docetaksel.
The Committee recommended that Docetaxel Teva be given marketing authorisation. 
Odbor je priporočil, da se za zdravilo Docetaxel Teva izda dovoljenje za promet.
• breast cancer. 
• raku dojke.
Docetaxel Teva is a ‘generic medicine'. 
Zdravilo Docetaxel Teva je „generično zdravilo“.
Docetaxel Teva can be used on its own after other treatments have failed. 
Zdravilo Docetaxel Teva se lahko uporablja kot monoterapija po neuspešnih drugih oblikah zdravljenja.
The active substance in Docetaxel Teva, docetaxel, belongs to the group of anticancer medicines known as the taxanes. 
Zdravilna učinkovina zdravila Docetaxel Teva, docetaksel, spada v skupino zdravil proti raku, imenovanih taksani.
Docetaxel Teva is used with cisplatin and 5-fluorouracil (other anticancer medicines); 
Zdravilo Docetaxel Teva se uporablja s cisplatinom in 5-fluoroacilom (drugima zdraviloma proti raku);
Why has Docetaxel Teva been approved? 
Zakaj je bilo zdravilo Docetaxel Teva odobreno?
Docetaxel Teva is a concentrate and solvent to be made up into a solution for infusion (drip) into a vein. 
Zdravilo Docetaxel Teva je koncentrat in vehikel za pripravo raztopine za infundiranje (kapalne infuzije) v veno.
Docetaxel Teva is used with prednisone or prednisolone (anti-inflammatory medicines); 
Zdravilo Docetaxel Teva se uporablja s prednizonom ali prednizolonom (protivnetnima zdraviloma);
Docetaxel Teva is an anticancer medicine. 
Zdravilo Docetaxel Teva je zdravilo proti raku.
What is Docetaxel Teva? 
Kaj je zdravilo Docetaxel Teva?
No additional studies were needed as Docetaxel Teva is given by infusion and contains the same active substance as the reference medicine, Taxotere. 
Zdravilo Docetaxel Teva se daje z infundiranjem in vsebuje isto zdravilno učinkovino kot referenčno zdravilo Taxotere, zato niso bile potrebne nobene dodatne študije.
How has Docetaxel Teva been studied? 
Kako je bilo zdravilo Docetaxel Teva raziskano?
What is Docetaxel Teva used for? 
Za kaj se zdravilo Docetaxel Teva uporablja?
How is Docetaxel Teva used? 
Kako se zdravilo Docetaxel Teva uporablja?
How does Docetaxel Teva work? 
Kako zdravilo Docetaxel Teva deluje?
It contains the active substance docetaxel. 
Vsebuje zdravilno učinkovino docetaksel.
• If you are over 65. 
• Če ste starejši od 65 let.
Black/African American Asian 
Črnci/afriški Američani Azijci
Date of first authorisation: 24 May 2013 Date of latest renewal: 19 April 2018 
Datum prve odobritve: 24. maj 2013 Datum zadnjega podaljšanja: 19. april 2018
3 These are drugs within class where similar interactions could be predicted. 
3 To so zdravila znotraj razreda, kjer je mogoče predvideti podobne interakcije.
No antagonism was observed for any of these combinations. 
Antagonizma niso opazili za nobeno od teh kombinacij.
b Week 144 window is between Day 967 and 1,050 (inclusive). 
b Okno v 144. tednu je med 967 in 1.050 dnevom (vključno z njima).
ATC code: J05AR09 
Oznaka ATC: J05AR09
Stribild reduces the amount of HIV in your body. 
Zdravilo Stribild zmanjša količino virusa HIV v vašem telesu.
1 When data available from drug interaction studies. 
1 Ko so razpoložljivi podatki iz študij medsebojnega delovanja zdravil.
This leaflet was last revised in <{MM/YYYY}> <{month YYYY}> 
Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}> <{mesec LLLL}>.
• Tell your doctor immediately if you become pregnant, think you may be pregnant or are planning to have a baby. 
• Zdravnika takoj obvestite, če zanosite, menite, da bi lahko bili noseči, ali načrtujete zanositev.
Stopping Stribild can seriously affect your response to future treatment. 
Prenehanje jemanja zdravila Stribild lahko resno vpliva na vaš odziv na prihodnje zdravljenje.
Moreover, the reversibility of renal toxicity cannot be fully ascertained. 
Poleg tega reverzibilnosti ledvične toksičnosti ni možno v celoti potrditi.
Mean age, years (range) 
Povprečna starost, leta (razpon)
INR should continue to be monitored during the first weeks following ceasing treatment with Stribild. 
INR je treba še naprej spremljati prve tedne po prenehanju zdravljenja z zdravilom Stribild.
These are mentioned above under the heading “Do not take Stribild - If you are taking one of these medicines”. 
Ta zdravila so navedena v poglavju »Ne jemljite zdravila Stribild - Če jemljete katero od naslednjih zdravil«.
It's important not to stop taking Stribild without talking to your doctor: see section 3, Do not stop taking Stribild. 
Pomembno je, da zdravila Stribild ne prenehate jemati, ne da bi se pogovorili z zdravnikom: glejte poglavje 3, Ne prenehajte jemati zdravila Stribild.
• contraceptive pill, used to prevent pregnancy 
• kontracepcijske tablete, ki se uporabljajo za preprečevanje nosečnosti
 Tell your doctor if you are taking these or any other medicines. 
 Povejte zdravniku, če jemljete ta ali katera koli druga zdravila.
• One tablet each day by mouth, with food. 
• ena tableta se zaužije vsak dan s hrano.
DOAC = direct oral anticoagulant 
DOAC = neposredni peroralni antikoagulant
When treating HIV infection, it is not always possible to tell whether some of the unwanted effects are caused by Stribild or by other medicines that you are taking at the same time, or by the HIV disease itself. 
Pri zdravljenju okužbe z virusom HIV ni vedno mogoče povedati, ali nekatere od naštetih neželenih učinkov povzroča zdravilo Stribild ali druga zdravila, ki jih jemljete sočasno, ali sama bolezen HIV.
Once you start taking Stribild, look out for: 
Ko začnete jemati zdravilo Stribild, bodite pozorni na:
If this is unavoidable, your doctor will monitor your kidney function more frequently. 
Če je to neizogibno, bo zdravnik bolj pogosto nadzoroval funkcijo vaših ledvic.
For both studies at 48 weeks, the virologic response rate was evaluated in both treatment arms. 
Za obe študiji so v 48. tednu stopnjo virološkega odziva ocenili v obeh skupinah zdravljenja.
Decreases in BMD of hip were significantly greater in this group until 96 weeks. 
Zmanjšanje BMD v kolku je bilo do 96 tednov značilno večje v tej skupini.
Therefore, a multidisciplinary approach is recommended to adequately weigh on a case by case basis the benefit/risk balance of treatment, decide the appropriate monitoring during treatment (including decision for treatment withdrawal) and consider the need for supplementation. 
Zato se priporoča multidisciplinarni pristop za ustrezno oceno razmerja med koristmi in tveganji zdravljenja, odločitev o ustreznem spremljanju med zdravljenjem (vključno z odločitvijo o prekinitvi zdravljenja) in razmislek o potrebi po dodatku za vsak posamični primer posebej.
Demographic characteristics 
Demografske značilnosti
Mean age was 15 years (range, 12−17), 70% were male, 68% black, 28% Asian. 
Povprečna starost je bila 15 let (razpon 12−17), 70 % je bilo moških, 68 % je bilo črncev, 28 % Azijcev.
Your doctor will carefully consider whether to treat you with Stribild. 
Vaš zdravnik bo skrbno pretehtal, ali naj vas zdravil z zdravilom Stribild.
BMD Z-scores were not adjusted for height and weight. 
Z-vrednost BMD ni bila prilagojena za višino in telesno maso.
If you are older than this and are prescribed Stribild, your doctor will monitor you carefully. 
Če ste starejši in so vam predpisali zdravilo Stribild, vas bo zdravnik skrbno nadzoroval.
Rarely, cases of pancreatitis and lactic acidosis, sometimes fatal, have been reported. 
Redko so poročali o primerih pankreatitisa in laktacidoze, ki so bili včasih smrtni.
2T = second trimester; 3T = third trimester; PP =postpartum a paired comparisons b P<0.10 compared with postpartum 
2T = drugi trimester; 3T = tretji trimester; PP = poporodno obdobje a sparjena primerjava b P < 0,10 v primerjavi s poporodnim obdobjem
6 Study conducted with additional voxilaprevir 100 mg to achieve voxilaprevir exposures expected in HCV-infected patients. 
6 Študijo so izvedli z dodatnim voksilaprevirjem 100 mg za doseganje izpostavljenosti voksilaprevirju, ki se pričakuje pri bolnikih z okužbo s HCV.
osteomalacia (manifested as bone pain and infrequently contributing to fractures)1,3,5, myopathy1,3 
osteomalacija (ki se kaže kot bolečine v kosteh in redko prispeva k zlomom)1,3,5, miopatija1,3
Tell your doctor or pharmacist if you are taking any other medicines or have recently taken any. 
Obvestite zdravnika ali farmacevta, če jemljete ali ste pred kratkim jemali katero koli drugo zdravilo.
As a result, the amounts of Stribild or other medicines in your blood may be affected. 
To lahko posledično vpliva na količino zdravila Stribild ali drugih zdravil v vaši krvi.
d Includes patients who discontinued due to adverse event or death at any time point from day 1 through the time window if this resulted in no virologic data on treatment during the specified window. 
d Vključuje bolnike, ki so prenehali sodelovati zaradi neželenih učinkov ali smrti, kadar koli od 1. dne do konca časovnega okna, če zaradi tega v določenem oknu ni bilo viroloških podatkov o zdravljenju.
• anaemia (low red blood cell count) 
• anemija (nizko število rdečih krvnih celic)
It is also important to tell your doctor if you are taking any of the following types of medicines: 
Pomembno je tudi, da zdravniku poveste, če jemljete katero od naslednjih vrst zdravil:
The film-coated tablet should not be chewed or crushed. 
Filmsko obložene tablete ni dovoljeno žvečiti ali zdrobiti.
• changes to your urine 
• spremembe urina
If you are affected while taking Stribild, do not drive and do not use any tools or machines. 
Če se vam v času zdravljenja z zdravilom Stribild pojavlja kaj od navedenega, ne vozite avtomobila in ne upravljajte z orodji ali stroji.
This will improve your immune system and reduce the risk of developing illnesses linked to HIV infection. 
S tem se vaš imunski sistem izboljša in zmanjša se tveganje za razvoj bolezni, povezanih z okužbo HIV.
e Includes subjects who discontinued for reasons other than an adverse event, death or lack or loss of efficacy, e.g., withdrew consent, loss to follow-up, etc. 
e Vključuje osebe, ki so sodelovanje prekinile zaradi drugih razlogov, kot so neželeni učinki, smrt ali pomanjkanje ali izguba učinka, npr. umik soglasja, izgubljeni za spremljanje itd.
Both emtricitabine and tenofovir have activity that is specific to human immunodeficiency virus (HIV-1 and HIV-2) and hepatitis B virus. 
Tako emtricitabin kot tenofovir imata aktivnost, ki je specifična za virus humane imunske pomanjkljivosti (HIV-1 in HIV-2) in virus hepatitisa B.
Adults and adolescents aged 12 years and older weighing at least 35 kg: One tablet, once daily with food. 
Odrasli in mladostniki, starih 12 let in več, ki tehtajo vsaj 35 kg: ena tableta enkrat dnevno s hrano.
Stribild has no or negligible influence on the ability to drive and use machines. 
Zdravilo Stribid nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
Alternative endothelin receptor antagonists may be considered. 
Razmisli se lahko o alternativnih antagonistih receptorjev endotelina.
• increased levels of creatine kinase in the blood that may result in muscle pain and weakness 
• zvišanje količine kreatin kinaze v krvi, ki lahko povzročijo bolečine in oslabelost mišic
Clinical monitoring is recommended due to the potential for hyperkalemia. 
Priporočeno je klinično spremljanje zaradi možnosti hiperkaliemije.
• low white blood cell count (which can make you more prone to infection) 
• nizko število belih krvnih telesc (kar lahko povzroči večjo nagnjenost k okužbam)
Due to limitations of the study, a benefit of tenofovir disoproxil over placebo was not demonstrated based on plasma HIV-1 RNA levels at week 24. 
Zaradi omejitev študije korist dizoproksiltenofovirata glede na placebo ni bila dokazana na podlagi plazemskih ravni RNA HIV-1 v 24. tednu.
hepatic steatosis1, hepatitis1 
hepatična steatoza1, hepatitis1
Stribild is not usually taken with other medicines that can damage your kidneys (see Other medicines and Stribild). 
Zdravila Stribild se ponavadi ne jemlje z drugimi zdravili, ki bi lahko poškodovala ledvice (glejte Druga zdravila in zdravilo Stribild).
It is especially important to talk to your doctor if you are taking any of the following: 
Posebno pomembno je, da zdravniku poveste, če jemljete kaj od naslednjega:
Tenofovir is primarily excreted by the kidney by both filtration and an active tubular transport system (human organic anion transporter [hOAT1]) with approximately 70-80% of the dose excreted unchanged in urine following intravenous administration. 
Tenofovir se primarno izloča preko ledvic tako s filtracijo kot z aktivnim tubularnim transportnim sistemom (humani prenašalec organskih anionov [hOAT1]), pri čemer se po intravenskem vnosu približno 70-80 % odmerka izloči nespremenjenega z urinom.
However, a large amount of data in pregnant women (more than1,000 pregnancy outcomes) indicate no malformations or foetal/neonatal toxicity associated with emtricitabine and tenofovir disoproxil. 
Vendar pa večje število podatkov pri nosečnicah (več kot 1.000 izpostavljenih nosečnosti) ne kaže na malformacije ali feto/neonatalno toksičnost, povezane z emtricitabinom in dizoproksiltenofoviratom.
If you vomit less than 1 hour after taking Stribild, take another tablet with food. 
Če bruhate manj kot 1 uro po zaužitju zdravila Stribild, vzemite še eno tableto s hrano.
The Marketing Authorisation Holder (MAH) shall ensure that all physicians who are expected to prescribe/use Stribild in adolescent patients are provided with a physician educational pack containing the following: 
Imetnik dovoljenja za promet z zdravilom bo zagotovil, da bodo vsi zdravniki, za katere se pričakuje, da bodo predpisovali/uporabljali zdravilo Stribild pri mladostnikih, prejeli izobraževalni paket za zdravnika, ki bo vseboval:
The transporters that cobicistat inhibits include P-gp, BCRP, OATP1B1 and OATP1B3. 
Transporterji, ki jih kobicistat zavira, vključujejo P-gp, BCRP, OATP1B1 in OATP1B3.
If you have HIV infection and hepatitis B, it is especially important not to stop your Stribild treatment without talking to your doctor first. 
Če ste okuženi z virusom HIV in hepatitisom B, je še zlasti pomembno, da ne prenehate z zdravljenjem z zdravilom Stribild, ne da bi se prej posvetovali z zdravnikom.
The interactions described are based on studies conducted with the components of Stribild as individual agents and/or in combination, or are potential drug interactions that may occur with Stribild. 
Opisane interakcije temeljijo na študijah, izvedenih z učinkovinami zdravila Stribild kot posamičnimi učinkovinami in/ali v kombinaciji, ali pa so možne interakcije z zdravili, ki se lahko pojavijo z zdravilom Stribild.
• lactic acidosis (see Possible serious side effects: tell a doctor immediately) 
• laktacidoza (glejte Možni resni neželeni učinki: takoj obvestite svojega zdravnika)
Possible serious side effects: tell a doctor immediately 
Možni resni neželeni učinki: takoj obvestite zdravnika
• passing a lot of urine and feeling thirsty (nephrogenic diabetes insipidus) 
• izločanje večjih količin urina in občutek žeje (nefrogeni diabetes insipidus)
• Children given emtricitabine very commonly experienced changes in skin colour including darkening of the skin in patches 
• Pri otrocih, ki so dobivali emtricitabin, so se zelo pogosto pojavile spremembe barve kože, vključno s - potemnitvijo kože v zaplatah
Eighteen of these 20 patients maintained virologic suppression through 48 weeks. 
Osemnajst od teh 20 bolnikov je ohranilo virusno supresijo do vključno konca 48. tedna.
Stribild should be taken orally, once daily with food (see section 5.2). 
Zdravilo Stribild se jemlje enkrat dnevno, peroralno s hrano (glejte poglavje 5.2).
4 Study conducted using Stribild. 
4 Študija opravljena z zdravilom Stribild.
If you take more Stribild than you should 
Če ste vzeli večji odmerek zdravila Stribild, kot bi smeli
Insufficient safety data are available for children below 12 years of age. 
Za otroke stare do 12 let so podatki o varnosti nezadostni.
Stribild is a single tablet regimen for the treatment of human immunodeficiency virus (HIV) infection in adults. 
Zdravilo Stribild je režim ene same tablete za zdravljenje okužbe z virusom humane imunske pomanjkljivosti (HIV) pri odraslih.
Aromatic and aliphatic hydroxylation or glucuronidation metabolites are present in very low levels, display considerably lower anti-HIV activity and do not contribute to the overall antiviral activity of elvitegravir. 
Aromatski in alifatski presnovki hidroksilacije ali presnovki glukuronidacije so prisotni v zelo nizkih ravneh, kar kaže na znatno nižjo aktivnost proti HIV in ne prispeva k splošni protivirusni aktivnosti elvitegravirja.
Each tablet contains 10.9 mg lactose (as monohydrate). 
Ena tableta vsebuje 10,9 mg laktoze (v obliki laktoze monohidrata).
Disopyramide Flecainide Systemic lidocaine Mexiletine Propafenone 
dizopiramid flekainid sistemski lidokain meksilitin propafenon
The MAH must agree the content and format of the medical educational pack with the national competent authority in each Member State prior to its distribution in their territory. 
Pred razdeljevanjem izobraževalnega paketa se mora imetnik dovoljenja za promet z zdravilom z nacionalno pristojnim organom v vsakih državi članici pred distribucijo zdravila na svojem ozemlju dogovoriti o vsebini in obliki medicinskega izobraževalnega paketa.
See also under Co-administration of other medicinal products below. 
Glejte tudi Sočasna uporaba drugih zdravil spodaj.
Stribild is not to be given with other antiretroviral medicinal products. 
Zdravila Stribild ni dovoljeno uporabljati z drugimi protiretrovirusnimi zdravili.
• and you notice within 18 hours of the time you usually take Stribild, you must take the tablet as soon as possible. 
• in to opazite v roku 18 ur od časa, ko zdravilo Stribild običajno vzamete, morate tableto vzeti čim prej.
The EC50 values for tenofovir were in the range of 0.04 to 8.5 µM. 
Vrednosti EC50 za tenofovir so bile v razponu od 0,04 do 8,5 µM.
• difficulty sleeping (insomnia), abnormal dreams 
• težave s spanjem (nespečnost), nenavadne sanje
2 Anaemia was common and skin discolouration (increased pigmentation) was very common when emtricitabine was administered to paediatric patients. 
2 Anemija je bila pogosta in sprememba obarvanosti kože (povečana pigmentacija) zelo pogosta pri pediatričnih bolnikih ob jemanju emtricitabina.
increased transaminases1, hyperbilirubinaemia1 
povišanje transaminaz1, hiperbilirubinemija1
Do not give this medicine to children under 12 years of age. 
Otrokom, starim manj kot 12 let, ne dajajte tega zdravila.
If you notice any symptoms of infection or other symptoms such as muscle weakness, weakness beginning in the hands and feet and moving up towards the trunk of the body, palpitations, tremor or hyperactivity, please inform your doctor immediately to seek necessary treatment. 
Če opazite katere koli simptome okužbe ali druge simptome, kot so oslabelost mišic, oslabelost, ki se začne v dlaneh in stopalih in se premika proti trupu, palpitacije, tresavico ali hiperaktivnost, o tem takoj obvestite svojega zdravnika, ki vas bo ustrezno zdravil.
Long term oral carcinogenicity studies with elvitegravir and cobicistat did not show any carcinogenic potential in mice and rats. 
Dolgoročne študije peroralne kancerogenosti z elvitegravirjem in kobicistatom niso pokazale kancerogenega potenciala pri miših in podganah.
• damage to kidney tubule cells 
• poškodba celic ledvičnih tubulov
Effects on drug levels Mean percent change in AUC, Cmax, 
Učinki na koncentracije učinkovin Srednja sprememba AUC, Cmax,
Lactic acidosis occurs more often in women - particularly if they are overweight and in people with liver disease. 
Laktacidoza se pogosteje pojavi pri ženskah, zlasti tistih s prekomerno telesno maso in pri ljudeh z jetrno boleznijo.
An assessment of benefit/risk ratio is recommended to justify use of voriconazole with Stribild. 
Priporoča se ocena razmerja med koristmi in tveganji, ki bi upravičila uporabo vorikonazola z zdravilom Stribild.
Seven patients had estimated glomerular filtration rate (GFR) values between 70 and 90 mL/min/1.73 m2. 
Sedem bolnikov je imelo ocenjene vrednosti hitrosti glomerularne filtracije (GFR- glomerular filtration rate) med 70 in 90 ml/min/1,73 m2.
If you forget to take Stribild 
Če ste pozabili vzeti zdravilo Stribild
The dual-drug combinations and the triple combination of elvitegravir, emtricitabine and tenofovir demonstrated synergistic activity in cell culture. 
Kombinacija dveh zdravil in trojna kombinacija elvitegravirja, emtricitabina in tenofovirja je pokazala sinergijsko aktivnost v celični kulturi.
• If you have liver problems or a history of liver disease, including hepatitis. 
• Če imate težave z jetri ali jetrne bolezni v anamnezi, vključno s hepatitisom.
this may cause the child to be tired or breathless 
- to lahko povzroči utrujenost ali zasoplost otroka
• If you stopped treatment with any medicine containing tenofovir disoproxil on the advice of your doctor following problems with your kidney function. 
• Če ste se prenehali zdraviti s katerim koli zdravilom, ki vsebuje dizoproksiltenofovirat po nasvetu zdravnika zaradi težav, ki so nastopile z delovanjem ledvic.
For information on other acid reducing agents (e.g. H2-receptor antagonists and proton pump inhibitors), see Studies conducted with other medicinal products. 
Za informacije o drugih zdravilih, ki zmanjšujejo kislino (npr. antagonisti receptorja H2 in zaviralci protonske črpalke) glejte Študije, opravljene z drugimi zdravili.
Primary mutations for raltegravir/elvitegravir do not affect the in vitro susceptibility of dolutegravir as single mutations, and the additional presence of secondary mutations (except Q148) also does not result in relevant fold changes in experiments with site directed mutants. 
Primarne mutacije za raltegravir/elvitegravir kot enkratne mutacije ne vplivajo na dovzetnost za dolutegravir in vitro, dodatna prisotnost sekundarnih mutacij (razen Q148) pa prav tako ni povzročila pomembnih sprememb stopenj v poskusih s točkovnimi mutanti.
Renal and bone effects in adults 
Učinki na ledvice in kosti pri odraslih
Pharmacotherapeutic group: Antivirals for systemic use; antivirals for treatment of HIV infections, combinations. 
Farmakoterapevtska skupina: Sistemski virostatiki; zdravila za sistemsko zdravljenje virusnih infekcij (HIV), kombinacije.